Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE

02 2AMLODIPINE BESYLATE

03 4ATORVASTATIN CALCIUM

04 2BUPROPION HYDROCHLORIDE

05 3ESCITALOPRAM OXALATE

06 3ESOMEPRAZOLE MAGNESIUM

07 2FAMOTIDINE

08 3FUROSEMIDE

09 3HYDROXYZINE HYDROCHLORIDE

10 3LORAZEPAM

11 3LOSARTAN POTASSIUM

12 2PANTOPRAZOLE SODIUM

13 3SPIRONOLACTONE

14 2TRAMADOL HYDROCHLORIDE

15 4TRAZODONE HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : TRAMADOL HYDROCHLORI...

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : TRAMADOL HYDROCHLORI...

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : TRAMADOL HYDROCHLORIDE AN...

Dosage Strength : 325MG;37.5MG

Packaging :

Approval Date : 2006-07-26

Application Number : 76914

Regulatory Info : DISCN

Registration Country : USA

blank

02

Brand Name : AMLODIPINE BESYLATE

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : AMLODIPINE BESYLATE

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : AMLODIPINE BESYLATE

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2012-04-13

Application Number : 201380

Regulatory Info : DISCN

Registration Country : USA

blank

03

Brand Name : AMLODIPINE BESYLATE

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : AMLODIPINE BESYLATE

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : AMLODIPINE BESYLATE

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2012-04-13

Application Number : 201380

Regulatory Info : DISCN

Registration Country : USA

blank

04

Brand Name : ATORVASTATIN CALCIUM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2018-06-18

Application Number : 209912

Regulatory Info : RX

Registration Country : USA

blank

05

Brand Name : ATORVASTATIN CALCIUM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2018-06-18

Application Number : 209912

Regulatory Info : RX

Registration Country : USA

blank

06

Brand Name : ATORVASTATIN CALCIUM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 40MG BASE

Packaging :

Approval Date : 2018-06-18

Application Number : 209912

Regulatory Info : RX

Registration Country : USA

blank

07

Brand Name : ATORVASTATIN CALCIUM

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : ATORVASTATIN CALCIUM

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ATORVASTATIN CALCIUM

Dosage Strength : EQ 80MG BASE

Packaging :

Approval Date : 2018-06-18

Application Number : 209912

Regulatory Info : RX

Registration Country : USA

blank

08

Brand Name : BUPROPION HYDROCHLOR...

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 150MG

Packaging :

Approval Date : 2019-01-28

Application Number : 211020

Regulatory Info : RX

Registration Country : USA

blank

09

Brand Name : BUPROPION HYDROCHLOR...

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : BUPROPION HYDROCHLOR...

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET, EXTENDED RELEASE...

Brand Name : BUPROPION HYDROCHLORIDE

Dosage Strength : 300MG

Packaging :

Approval Date : 2019-01-28

Application Number : 211020

Regulatory Info : RX

Registration Country : USA

blank

10

Brand Name : ESCITALOPRAM OXALATE

Aus. Peptide Conference
Not Confirmed
arrow

Brand Name : ESCITALOPRAM OXALATE

arrow
Aus. Peptide Conference
Not Confirmed

Graviti Pharmaceuticals

Dosage Form : TABLET;ORAL

Brand Name : ESCITALOPRAM OXALATE

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2012-09-11

Application Number : 78777

Regulatory Info : RX

Registration Country : USA

blank